Copilot Pro+ and Copilot Enterprise users now can run multiple coding agents directly inside GitHub, GitHub Mobile, and ...

A pedestrian was struck by an SUV and another vehicle Tuesday morning while crossing a Studio City street and left to die by the motorists, authorities said. The hit-and-run crash was reported at 5:44 ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

For fixing Windows errors, we recommend Fortect: Fortect will identify and deploy the correct fix for your Windows errors. Follow the 3 easy steps to get rid of Windows errors: Follow these steps to ...

No matter your current running pace and typical distance, in How to Run Faster, certified run coach Matt Meyer and other experts will help you speed up! You will learn crucial speed workouts, ...

Shares of Replimune Group, Inc. (NASDAQ:REPL) are rising Monday after the clinical stage biotechnology company shared an important regulatory update. What To Know: Replimune said the U.S. Food and ...

Dominik Bošnjak is a freelance writer from Croatia. He has been writing about games for as long as he can remember and began doing so professionally in 2010 because an opportunity presented itself ...

Microsoft Visual Studio 2026 Arrives With ‘AI Woven Into Workflow’ Your email has been sent First major visual studio upgrade in five years AI, performance, and ...

Oasis Security has uncovered a flaw in the widely used AI-powered code editor Cursor that lets malicious repositories silently execute code the moment a developer opens them. According to a disclosure ...

A newly disclosed flaw in the Cursor extension allows repositories to automatically execute code when a folder is opened, even without a developer’s consent. The issue stems from the extension’s ...

Shares of Replimune (NASDAQ:REPL) plunged ~38% in the premarket on Monday after Stat News reported that the FDA’s top regulator of cancer drugs intervened during the review of the company’s lead asset ...